K172195

Substantially Equivalent

HYDRASHIFT 2/4 daratumumab, daratumumab Control

Applicant: Sebia
Product code: CFF
Advisory panel: Immunology
Date received: 2017-07-21
Decision date: 2018-01-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Norcross, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.